Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal Platelets
Status:
Unknown status
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
The specific objective of this study is to investigate the potential for normal platelets to
reverse the inhibition of platelet aggregation in patients treated with ticagrelor in
combination with aspirin.